Shi Lian Zi

Sinocrassula indica (Decne.) A.Berger

Also known as: Indian Sinocrassula Sinocrassula(English)

Shih Lien Tzŭ

Updated October 5, 2026 · Not yet clinically reviewed

Safety at a glance

Note

3 recorded drug interactions

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
clearing heat
Temperature
Cold
Taste
Bitter
Channels
Large Intestine,Bladder,Stomach

Functions

Clears Heat

Traditional uses

This record fixes Shi Lian Zi to Sinocrassula indica (Crassulaceae), Herba Sinocrassulae Indicae (石莲花) — one arm of a three-way 石莲子 homonym, distinct from aged lotus seed and from Salacia. A bitter, cold heat-clearing herb, it enters the Large Intestine, Bladder and Stomach channels and is used chiefly to clear Heat and resolve toxicity.

The whole succulent herb is applied to Heat and toxic-Heat patterns, including damp-heat dysentery and diarrhea, hot painful urinary dribbling (lin) reflecting its Bladder affinity, and Stomach Heat. Externally the fresh herb is pounded and applied to boils, sores, swellings and burns. It is generally decocted internally or used topically. Being bitter and cold, it is inappropriate for Spleen-Stomach deficiency-cold with loose stools.

Formulas using this herb

1 of 1 formulas

Botanical

This Shi Lian Zi is the whole herb of Sinocrassula indica (Crassulaceae), a biennial succulent of rocky slopes and cliffs from the Himalaya to south-west China. In the first year it forms a dense basal rosette of fleshy, oblanceolate to spatulate leaves; the flowering stem then elongates to 15-60 cm and bears further reduced leaves and an elongate thyrse of small five-merous flowers with erect, fleshy, reddish to purplish petals and pointed anthers. The plant is glabrous and glaucous, storing water in its thick tissues. The whole succulent herb is used to clear heat, cool the blood, stop bleeding and resolve toxicity — for sore throat, dysentery, intestinal bleeding, hemoptysis, burns and traumatic wounds.

Family
Crassulaceae
Pharmaceutical name
Herba Sinocrassulae Indicae
Native region
China, Nepal, India, Bhutan, Myanmar

Habitat

Rocky slopes, cliffs and dry grassy hillsides, roughly 1000-3800 m elevation.

Constituents

Sinocrassosides A1, A2, B1 and B2

Acylated flavonol glycoside

Four acylated flavonol glycosides isolated from the methanolic extract of the whole plant alongside eleven other flavonoids and two megastigmanes. They are the compounds most closely associated with the hypoglycaemic activity of the crude extract in rodents, though none has been shown individually to lower blood glucose in vivo.

Sinocrassosides B4, B5, C1 and D1-D3

Acylated flavonol glycoside

Six further flavonol glycosides from the whole plant. Constituents of this fraction inhibited aminopeptidase N and aldose reductase in enzyme assays, the latter being the polyol-pathway enzyme implicated in diabetic cataract and neuropathy.

Sinocrassosides A8-A12

Acylated flavonol glycoside

Five acylated flavonol glycosides isolated during the work that showed the methanolic whole-plant extract protects primary cultured mouse hepatocytes against D-galactosamine-induced cytotoxicity.

Megastigmanes

C13 norisoprenoid

Two megastigmane derivatives accompany the flavonol glycosides in the whole-plant extract. No specific activity has been attributed to them in this species.

Drug interactions

Shi Lian Zi as Semen Nelumbinis (aged lotus fruit, Nelumbo nucifera) - dispensing substitution

Moderate · The wrong drug is dispensed; a Crassulaceae succulent with essentially no clinical literature is supplied where a lotus-family astringent was intended, or the reverse · Evidence level: Possible

In standard Chinese materia medica the name Shi Lian Zi denotes the hardened mature fruit of Nelumbo nucifera (lotus), used for chronic dysentery and for restoring appetite, whereas Sinocrassula indica is the succulent Shi Lian of the Crassulaceae. The two share the name but belong to unrelated families and have unrelated actions. The record in front of you is grounded on the binomial Sinocrassula indica; nothing in the lotus literature applies to it.

Clinical note: Verify by binomial on the supplier certificate before dispensing anything labelled Shi Lian Zi. If the intent was the lotus drug for chronic diarrhoea, this species is not a substitute.

Insulin, sulfonylureas and other glucose-lowering drugs

Theoretical · Possible additive fall in blood glucose · Evidence level: Theoretical

The methanolic whole-plant extract suppressed the rise in serum glucose after oral sucrose and glucose loading in rats at 250 mg/kg, and lowered glucose in genetically diabetic KK-Ay mice over two weeks at the same daily dose. The rat effect disappeared when glucose was given intraperitoneally and the extract partly delayed gastric emptying, so the mechanism looks largely luminal rather than systemic. No human data exist and no dose equivalence to a clinical decoction has been established.

Clinical note: If a diabetic patient uses this herb, monitor capillary glucose during the first weeks rather than assuming no effect.

Aldose reductase inhibitors (e.g. epalrestat)

Theoretical · Unknown; additive enzyme inhibition is plausible but unmeasured · Evidence level: Theoretical

Several constituents of the whole-plant extract inhibited aldose reductase in a cell-free assay. Whether these flavonol glycosides reach the lens or peripheral nerve after oral dosing has never been examined, so the finding is a chemical observation and not a demonstrated pharmacological effect.

Clinical note: No action needed; record the concurrent use rather than adjusting therapy on the basis of an in vitro result.

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
3

Bioactive Constituents from Chinese Natural Medicines. XXIV. Hypoglycemic Effects of Sinocrassula indica in Sugar-Loaded Rats and Genetically Diabetic KK-Ay Mice and Structures of New Acylated Flavonol Glycosides, Sinocrassosides A1, A2, B1, and B2

Masayuki Yoshikawa; Tao Wang; Toshio Morikawa; Haihui Xie; Hisashi Matsuda · Chemical and Pharmaceutical Bulletin · 2007 · animal

In vitro / animal · Verified

The methanolic whole-plant extract of Sinocrassula indica at 250 mg/kg orally blunted the rise in serum glucose after oral sucrose or glucose in rats, but had no effect when glucose was given intraperitoneally, and it partly inhibited gastric emptying, pointing to a luminal mechanism. Given at 250 mg/kg/day for two weeks to genetically type II diabetic KK-Ay mice it significantly reduced serum glucose without changing body, liver or visceral fat weight. Four new acylated flavonol glycosides, sinocrassosides A1, A2, B1 and B2, were isolated together with eleven flavonoids and two megastigmanes.

doi:10.1248/cpb.55.1308

Bioactive Constituents from Chinese Natural Medicines. XXXII. Aminopeptidase N and Aldose Reductase Inhibitors from Sinocrassula indica: Structures of Sinocrassosides B4, B5, C1, and D1-D3

Toshio Morikawa; Haihui Xie; Tao Wang; Hisashi Matsuda; Masayuki Yoshikawa · Chemical and Pharmaceutical Bulletin · 2008 · in vitro

In vitro / animal · Not yet verified

Six new flavonol glycosides, sinocrassosides B4, B5, C1 and D1 to D3, were isolated from the methanolic whole-plant extract along with thirty known compounds. Several constituents inhibited aminopeptidase N and aldose reductase in enzyme assays. The work is chemical and cell-free; no animal or human confirmation of these enzyme effects has followed.

doi:10.1248/cpb.56.1438

Bioactive Constituents from Chinese Natural Medicines. XXXI. Hepatoprotective Principles from Sinocrassula indica: Structures of Sinocrassosides A8, A9, A10, A11, and A12

Masayuki Yoshikawa; Kiyofumi Ninomiya; Toshio Morikawa; Haihui Xie; Hisashi Matsuda · HETEROCYCLES · 2008 · in vitro

In vitro / animal · Not yet verified

The methanolic extract of the whole plant protected primary cultured mouse hepatocytes against D-galactosamine-induced cytotoxicity, and five new acylated flavonol glycosides, sinocrassosides A8 to A12, were characterised from it together with twenty-five other compounds. The hepatoprotection is a cultured-hepatocyte result and has not been reproduced in a whole animal or in patients.

doi:10.3987/com-08-11385

References

  1. Masayuki Yoshikawa; Tao Wang; Toshio Morikawa; Haihui Xie; Hisashi Matsuda. Bioactive Constituents from Chinese Natural Medicines. XXIV. Hypoglycemic Effects of Sinocrassula indica in Sugar-Loaded Rats and Genetically Diabetic KK-Ay Mice and Structures of New Acylated Flavonol Glycosides, Sinocrassosides A1, A2, B1, and B2. Chemical and Pharmaceutical Bulletin. 2007 doi:10.1248/cpb.55.1308
  2. Toshio Morikawa; Haihui Xie; Tao Wang; Hisashi Matsuda; Masayuki Yoshikawa. Bioactive Constituents from Chinese Natural Medicines. XXXII. Aminopeptidase N and Aldose Reductase Inhibitors from Sinocrassula indica: Structures of Sinocrassosides B4, B5, C1, and D1-D3. Chemical and Pharmaceutical Bulletin. 2008 doi:10.1248/cpb.56.1438
© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice